糖化血红蛋白检测对糖尿病微血管病变评估的价值

摘要

Objective To study the glycosylated hemoglobin (HbAlc) to detect the value of the evaluation of diabetic microangiopathy.Methods From March 2015 to March 2016, 89 cases of patients with diabetes were selected as the study object and were divided into microvascular lesion group (48 cases), non-microvascular lesion group (41 cases). At the same time, 40 cases of healthy persons were selected as a control, HbAlc and fasting blood glucose (FBG) levels were detected in the two groups.Results The levels of HbAlc and FBG in patients with microvascular disease were significantly higher than in the control group and the control group. The difference was statistically signiifcant (P<0.05); The levels of HbAlc and FBG were significantly higher in the control group than in the control group. The difference was statistically significant (P<0.05).Conclusion HbAlc detection can be used to assess the occurrence and development of diabetic microvascular disease, and it can be used as the standard of early diagnosis of diabetes.%目的：探讨糖化血红蛋白（HbAlc）检测对糖尿病微血管病变评估的价值。方法收集我院2015年3月～2016年3月89例糖尿病患者，依据病症分成微血管病变组（48例）、无微血管病变组（41例），且收集同时期的健康体检者40例作为对照组进行临床比较，检测两组观察对象的HbAlc和空腹血糖（FBG）水平。结果微血管病变组患者的HbAlc、FBG水平与无微血管病变组、对照组比较均明显较高，差异具有统计学意义（P＜0.05）；无微血管病变组的HbAlc、FBG水平，与对照组比较明显较高，差异具有统计学意义（P＜0.05）。结论 HbAlc检测应用于糖尿病微血管病变的评估可有效判断其发生、发展过程，可作为糖尿病的早期诊断的标准。